2022 Health Care Outlook: How the Biotech Industry is Adapting to COVID-19 | J.P. Morgan
What are some of the key themes for the biotech industry in 2022? Jess Fye, Senior Analyst for U.S. Biotechnology at J.P. Morgan Research discusses the outlook for the sector, highlighting major themes including M&A activity, the IPO pipeline, and innovation in cell and gene therapy.
SUBSCRIBE: http://jpm.com/x/i/NFPWfK0
About J.P. Morgan:
J.P. Morgan is a leader in financial services, offering solutions to clients in more than 100 countries with one of the most comprehensive global product platforms available. We have been helping our clients to do business and manage their wealth for more than 200 years. Our business has been built upon our core principle of putting our clients’ interests first.
Connect with J.P. Morgan Online:
Visit the J.P. Morgan Website: https://www.jpmorgan.com/
Follow @jpmorgan on Twitter: https://twitter.com/jpmorgan
Visit our J.P. Morgan Facebook page: http://facebook.com/jpmorgan
Follow J.P. Morgan on LinkedIn: https://linkedin.com/company/j-p-morgan/
Follow @jpmorgan on Instagram: https://instagram.com/jpmorgan/
#JPMorgan #HealthcareOutlook #Biotech
2022 Health Care Outlook: How the Biotech Industry is Adapting to COVID-19 | J.P. Morgan
source
Disclaimer: This content including advice provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information.
Keywords: corporate banking,jp morgan investment banking,investment banking jp morgan,corporate investment banking,corporate and investment banking,jp morgan internship,j.p. morgan internship,jp morgan,jpmorgan chase,investment banking,investment banker,corporate baking,investment banking lifestyle,j p morgan,life of an investment banker,jp morgan careers